1. Home
  2. ARVN vs REAX Comparison

ARVN vs REAX Comparison

Compare ARVN & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$8.10

Market Cap

516.2M

Sector

Health Care

ML Signal

HOLD

Logo The Real Brokerage Inc.

REAX

The Real Brokerage Inc.

HOLD

Current Price

$2.12

Market Cap

435.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARVN
REAX
Founded
2015
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
516.2M
435.9M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
ARVN
REAX
Price
$8.10
$2.12
Analyst Decision
Buy
Strong Buy
Analyst Count
19
5
Target Price
$15.05
$5.49
AVG Volume (30 Days)
685.8K
4.4M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
58.84
N/A
EPS
N/A
N/A
Revenue
$262,600,000.00
N/A
Revenue This Year
N/A
$23.04
Revenue Next Year
N/A
$15.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.06
$1.55
52 Week High
$14.22
$5.41

Technical Indicators

Market Signals
Indicator
ARVN
REAX
Relative Strength Index (RSI) 46.57 56.73
Support Level N/A $1.59
Resistance Level $8.90 $2.30
Average True Range (ATR) 0.38 0.16
MACD 0.01 0.01
Stochastic Oscillator 22.00 62.77

Price Performance

Historical Comparison
ARVN
REAX

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

Share on Social Networks: